Dermatomyositis: clinical features
Written and reviewed by Dr Ibrahim Imam, Consultant Neurologist. Last reviewed .
Dermatomyositis: clinical features. Exposure to ultraviolet light, TIF1 gene mutations, Some class 2 HLA alleles. Fully referenced neurology checklist.
Possible risk factors
- Exposure to ultraviolet light
- TIF1 gene mutations
- Some class 2 HLA alleles
Major dermatological features
Locked: subscribe to see this section.
Other dermatological features
Locked: subscribe to see this section.
Neurological features
Locked: subscribe to see this section.
Oral features
Locked: subscribe to see this section.
Anti-MDA5 features
Locked: subscribe to see this section.
Associated disorders
Locked: subscribe to see this section.
References
- Dalakas MC. Therapeutic advances and future prospects in immune-mediated inflammatory myopathies. Ther Adv Neurol Disord 2008; 1:157-166.
- Mammen AL. Dermatomyositis and polymyositis: Clinical presentation, autoantibodies, and pathogenesis. Ann N Y Acad Sci 2010; 1184:134-153.
- Amato AA, Barohn RJ. Evaluation and treatment of inflammatory myopathies. JNNP 2009; 80:1060-1068.
- Selva-O'Callaghan A, Pinal-Fernandez I, Trallero-Araguás E, Milisenda JC, Grau-Junyent JM, Mammen AL. Classification and management of adult inflammatory myopathies. Lancet Neurol 2018; 17:816-828.
- Marvi U, Chung L, Fiorentino D. Clinical presentation and evaluation of dermatomyositis. Indian J Dermatol 2012; 57:375-381.
- And 10 more. Subscribe to see the full list
